Plasmonics and photonics have been drawing attention in both academia and industry due to their use in an extensive range of applications, one of which includes optical sensing. The development of optical sensing technology not only contributes to the scientific research community as a versatile tool, but also offers substantial commercial value for smart city and Internet of Things (IOT) applications due to its energy efficiency, lightweight, small size and suitability for remote sensing. Reinforcing its significance, Scientific American identified plasmonic sensing as one of the top 10 emerging technologies of 2018.
* This article was originally published here
Sunday, 19 May 2019
Scientists capture first-ever video of body's safety test for T-cells
For the first time, immunologists from The University of Texas at Austin have captured on video what happens when T-cells—the contract killers of the immune system, responsible for wiping out bacteria and viruses—undergo a type of assassin-training program before they get unleashed in the body. A new imaging technique that allowed for the videos, described today in the journal Nature Communications, holds promise for the fight against autoimmune disorders such as Type 1 diabetes.
* This article was originally published here
* This article was originally published here
Sugary drinks and fruit juice may increase risk of early death
(HealthDay)—Most folks know that sugary drinks aren't healthy, but a new study finds fruit juices are not much better.
* This article was originally published here
* This article was originally published here
Microsoft alerts hospitals to fix potential security risk
Computer experts inside hospitals were working diligently on Wednesday to address a serious new security vulnerability in older versions of the Windows operating system, which is still used in many health care devices even though Microsoft hasn't actively supported the older software in years.
* This article was originally published here
* This article was originally published here
FDA approves venetoclax for chronic, small lymphocytic leukemia
(HealthDay)—Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma, the U.S. Food and Drug Administration announced yesterday.
* This article was originally published here
* This article was originally published here
Being sick in the morning can be different from being sick at night
In a review published May 17 in the journal Trends in Immunology, researchers discuss how time of day affects the severity of afflictions ranging from allergies to heart attacks.
* This article was originally published here
* This article was originally published here
For many HIV+ women, daily survival takes precedence over viral suppression
According to scientists who study women infected with HIV, statistics often paint an impressionist view of the lives of these women that misses the granular detail that tells the real story. The imprecise big picture is that most of this population is doing a good job at suppressing the virus, but facts gathered on the ground show that many struggle with issues of daily living that can make taking a pill to keep HIV at bay difficult.
* This article was originally published here
* This article was originally published here
Facebook breakup could boost China rivals: Sandberg
Facebook chief operating officer Sheryl Sandberg said Friday a breakup of big US technology would not address "underlying issues" facing the sector and suggested that such a move could help rivals in China.
* This article was originally published here
* This article was originally published here
Here's why your internet may be delivered by a drone someday soon
As the pilotless flying wing came in for a landing, winds suddenly picked up. Facebook Inc.'s Aquila drone—powered by the sun and wider than a Boeing 737 jetliner—struggled to adjust. Just before landing, part of the right wing broke off.
* This article was originally published here
* This article was originally published here
Clinical trial improves treatment of genetic rickets
A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. The findings are published in Lancet.
* This article was originally published here
* This article was originally published here
A new era in 3-D printing
In the mid-15th century, a new technology that would change the course of history was invented. Johannes Gutenberg's printing press, with its movable type, promoted the dissemination of information and ideas that is widely recognized as a major contributing factor for the Renaissance.
* This article was originally published here
* This article was originally published here
Eyes in the sky project will show power plant pollution marks
Air pollution is responsible for millions of deaths every year, worldwide. According to a State of Global Air report, air pollution is the fifth greatest global mortality risk.
* This article was originally published here
* This article was originally published here
Mercedes want to abandon combustion engines by 2039
German giant Mercedes-Benz said Monday it wants to stop selling traditional combustion engine cars by 2039 and plans for its new vehicles sold worldwide by that time to be carbon-neutral.
* This article was originally published here
* This article was originally published here
Researchers unravel mechanisms that control cell size
Working with bacteria, a multidisciplinary team at the University of California San Diego has provided new insight into a longstanding question in science: What are the underlying mechanisms that control the size of cells?
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)